77 related articles for article (PubMed ID: 1704879)
1. Chemotherapy for stage IV non-small cell lung cancer.
Bitran JD; Vokes EE
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1159-68. PubMed ID: 1704879
[TBL] [Abstract][Full Text] [Related]
2. Sequential combined modality therapy for stage III non-small cell lung cancer.
Vokes EE
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Bonomi P; Reddy S; Faber LP
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in stage-IV NSCLC.
Reck M; Gatzemeier U
Lung Cancer; 2004 Aug; 45 Suppl 2():S217-22. PubMed ID: 15552802
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
8. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
11. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
13. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
Kubota K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
[TBL] [Abstract][Full Text] [Related]
14. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
Müller H
Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
[TBL] [Abstract][Full Text] [Related]
16. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
Rapp E; Pater JL; Willan A; Cormier Y; Murray N; Evans WK; Hodson DI; Clark DA; Feld R; Arnold AM
J Clin Oncol; 1988 Apr; 6(4):633-41. PubMed ID: 2833577
[TBL] [Abstract][Full Text] [Related]
18. [Latest therapeutic strategy for stage IV non-small cell lung cancer].
Kawate N
Nihon Rinsho; 2002 May; 60 Suppl 5():490-3. PubMed ID: 12101720
[No Abstract] [Full Text] [Related]
19. Progress against rare and not-so-rare cancers.
Chabner BA; Friedman MA
N Engl J Med; 1992 Feb; 326(8):563-5. PubMed ID: 1310161
[No Abstract] [Full Text] [Related]
20. Chemotherapy versus best supportive care for advanced non-small-cell lung cancer.
Abang AM
Am J Health Syst Pharm; 1996 Dec; 53(24):2980-4. PubMed ID: 8974162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
